High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.
about
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal modelDurable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesImpact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusSeroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesA comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus.Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons.Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.Current status on the development of pseudoviruses for enveloped viruses.Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.The Use of Limited Fluid Resuscitation and Blood Pressure-Controlling Drugs in the Treatment of Acute Upper Gastrointestinal Hemorrhage Concomitant with Hemorrhagic Shock.
P2860
Q21131365-744ECD6F-9C8B-49B0-A737-7371110111C7Q28603888-0A46F98E-C502-45C0-A14E-7DBB37B79FA0Q33591582-20B8ED3D-0256-41BB-97F3-62908C6CD7E2Q33723312-36B85ACD-DB78-436E-AFE8-FE73529F6823Q33856453-AA844C52-3FFC-4DFF-BD63-AA00F45E4553Q35109451-EF5D4D91-2DC2-453F-BB69-448ADD504020Q35773930-18B5CE69-6BE5-4769-8A21-7D9819A012B8Q35887709-6EA12106-10AB-47A9-A1D9-D32FC6B0809CQ36846030-6A0D780E-F952-4BA2-83FE-7727CCE11BA4Q36977831-D001F12B-4D35-4BEC-8FB3-0250D4C5436CQ37710523-0B240B20-3803-4ECC-9A32-16F3C4AA89DDQ37712837-5A60F7E3-C8DE-48E6-84D1-C5B7A32ECA4FQ38671633-51DD9B66-7C66-4DD8-AFD4-3E8918E1E500Q42214731-372EB254-B10C-4495-ACF1-970E2F5B4CE1Q42239419-931208A8-4D34-4DFE-A0C2-60D4FDCFB479Q47549756-03CB33BC-4F18-4DC8-97C4-7CA296C6A033Q47568014-C64E8A3D-CB47-4D23-8402-C015E02B18F3Q52631712-7D66343B-76B7-4E54-87D8-2A24DC41421AQ52977647-297811AC-9BFD-480D-A3F8-F48CADD01315
P2860
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@ast
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@en
type
label
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@ast
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@en
prefLabel
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@ast
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@en
P2093
P2860
P1433
P1476
High-throughput pseudovirion-b ...... gainst human papillomaviruses.
@en
P2093
Hanna Seitz
Ivonne Rubio
Kerstin Putzker
Lis Ribeiro-Müller
Martin Müller
Peter Sehr
P2860
P304
P356
10.1371/JOURNAL.PONE.0075677
P407
P577
2013-10-04T00:00:00Z